Benfluorex-induced severe primary tricuspid and mitral regurgitation requiring a double-valve replacement

Eur J Cardiothorac Surg. 2018 Jul 1;54(1):195. doi: 10.1093/ejcts/ezy032.

Authors

Marc Eugène¹, Patrick Bruneval², Nicolas Bonnet³, David Attias¹

Affiliations

¹ Department of Cardiology, Centre Cardiologique du Nord, Saint Denis, France.
² Department of Pathology, Hôpital Européen Georges Pompidou, Paris-Descartes University, Paris, France.
³ Department of Cardiac Surgery, Centre Cardiologique du Nord, Saint Denis, France.

PMID: 29444226
DOI: 10.1093/ejcts/ezy032

No abstract available

Publication types

Case Reports

MeSH terms

Fenfluramine / adverse effects
Fenfluramine / analogs & derivatives*
Heart Valve Prosthesis Implantation*
Humans
Hypolipidemic Agents / adverse effects*
Mitral Valve Insufficiency / chemically induced*
Mitral Valve Insufficiency / pathology
Mitral Valve Insufficiency / surgery
Tricuspid Valve Insufficiency / chemically induced*
Tricuspid Valve Insufficiency / pathology
Tricuspid Valve Insufficiency / surgery

Substances

Hypolipidemic Agents
Fenfluramine
benfluorex